(19)
(11) EP 2 841 462 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
12.10.2016 Bulletin 2016/41

(45) Mention of the grant of the patent:
06.07.2016 Bulletin 2016/27

(21) Application number: 13724511.4

(22) Date of filing: 25.04.2013
(51) International Patent Classification (IPC): 
C08B 37/08(2006.01)
(86) International application number:
PCT/CZ2013/000057
(87) International publication number:
WO 2013/159757 (31.10.2013 Gazette 2013/44)

(54)

CROSSLINKED HYALURONAN DERIVATIVE, METHOD OF PREPARATION THEREOF, HYDROGEL AND MICROFIBERS BASED THEREON

VERNETZTES HYALURONANDERIVAT, VERFAHREN ZUR HERSTELLUNG DAVON, HYDROGEL UND MIKROFASERN AUF BASIS DAVON

DÉRIVÉ D'HYALURONANE RÉTICULÉ, SON PROCÉDÉ DE PRÉPARATION, HYDROGEL ET MICROFIBRES À BASE DU DÉRIVÉ

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 25.04.2012 CZ 20120282

(43) Date of publication of application:
04.03.2015 Bulletin 2015/10

(73) Proprietor: Contipro a.s.
56102 Dolni Dobrouc (CZ)

(72) Inventors:
  • HUERTA-ANGELES, Gloria
    56002 Ceska Trebova (CZ)
  • JOUKLOVA, Zuzana
    57001 Litomysl (CZ)
  • PRIKOPOVA, Eva
    56164 Techonin (CZ)
  • VELEBNY, Vladimir
    56401 Zamberk (CZ)

(74) Representative: Dvorakova, Martina 
Kania, Sedlak, Smola Patent Attorneys Mendlovo namesti 1 a
CZ-603 00 Brno
CZ-603 00 Brno (CZ)


(56) References cited: : 
EP-A2- 2 399 940
WO-A1-2010/051783
 WO-A1-02/18450
WO-A2-2011/069474
   
  • JUNSEOK YEOM ET AL: "Effect of Cross-Linking Reagents for Hyaluronic Acid Hydrogel Dermal Fillers on Tissue Augmentation and Regeneration", BIOCONJUGATE CHEMISTRY, vol. 21, no. 2, 17 February 2010 (2010-02-17), pages 240-247, XP055045386, ISSN: 1043-1802, DOI: 10.1021/bc9002647
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).